RITUXAN therapy

Your Follicular Lymphoma journey continues with maintenance therapy

Your doctor may decide to prescribe RITUXAN as maintenance therapy if you achieve remission after using RITUXAN and chemotherapy as initial treatment. RITUXAN is prescribed alone, without chemotherapy, every 8 weeks for 12 doses during this phase of the journey. Your goal here is to help keep your disease in remission.

In one study of patients with follicular lymphoma who received RITUXAN maintenance therapy (after responding to initial RITUXAN therapy plus chemotherapy), patients cut the risk of their disease advancing by almost half (46%) compared with patients who did not receive additional treatment after initial therapy. These results were from a clinical trial and may not be the same as what you experience.

RITUXAN is given once every 8 weeks for 12 doses as maintenance therapy. Severe side effects reported were infections and decreased white blood cell counts.

Maintenance therapy infusion schedule for follicular lymphoma

Select Important Safety Information

RITUXAN for the treatment of follicular CD20-positive non-Hodgkin's lymphoma as an initial treatment with chemotherapy, and in patients whose initial treatment was successful, as a single-agent follow-up therapy

Severe side effects reported were infections and decreased white blood cell counts. The most frequently reported side effect was infections.

NEXT: DIFFUSE LARGE B-CELL LYMPHOMA

RITUXAN is available by prescription only.